CONTINUOUS SUBCUTANEOUS INSULIN INFUSION FOR INITIAL TREATMENT OF TYPE-1 DIABETES-MELLITUS - PILOTE STUDY FOR AN OUTPATIENT STARTING INSULIN-TREATMENT

Most textbooks adwise that newly diagnosed insulin dependent mellitus be admitted to the hospital for starting carefully insulin treatment. We report a pilote study for starting an outpatient insulin using cont inuous subcutaneous insulin infusion. In 40 newly IDDM (glycaemia over 16.5 mM/l, CO2 over 15 mM/l), intensive therapy was done by CSII = ba sal rate 1 unit/hour, bolus 5 units per meal. After a long explanary t alk (4 hours) with the physician and the nurse on hypo, hyperglycaemia , on blood glucose sensor and pump, 21 patients agreed to start insuli n at home and 19 remained in hospital for 2 or 7 days. At days 3, 30 a nd 365, clinical and biological evaluation was done and at D30 patient education program for 5 days was undergone. Never emergency even was reported in any patient, and no difference appeared between the in and out patient in Dl, D3 and D365 normalisation of blood glucose (3 days ) or level cetone body (2 days) and total insulin dose. Our results su ggest that outpatient is a safe and cost effective IDDM onset therapy.